Biotechnology company
Drug pricing under 340B program and drug pricing issues generally; Legislation related to repeal and replace of the Affordable Care Act (H.R. 1628 American Healthcare Act of 2017); PDUFA Drug pricing under 340B program and drug pricing issues generally; Legislation related to repeal and replace of the Affordable Care Act (H.R. 1628 American Healthcare Act of 2017); PDUFA
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo)
LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo